Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Psychopharmacology
|
September 17, 2008
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
Masataka Wakeno, Masaki Kato, Gaku Okugawa, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis
Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.
Neuropsychobiology
|
November 27, 2015
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Journal of Affective Disorders
|
July 19, 2023
Relationship between circulating mitochondrial DNA and microRNA in patients with major depression
Haruhiko Ogata, Koichiro Higasa, Yuki Kageyama, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2015
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Diabetes Care
|
January 28, 2003
MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation
Makiko Maeda, Isamu Yamamoto, Masakatsu Fukuda, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 29, 2015
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
December 3, 2015
Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study
Azusa Suwa, Keiichiro Nishida, Keita Utsunomiya, et al.
International Journal of Cardiology
|
December 19, 2012
Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study
Hiroshi Okamoto, Masatsugu Hori, Masunori Matsuzaki, et al.
European Journal of Clinical Pharmacology
|
March 11, 2019
Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients
Maki Sasano, Masako Ohno, Yuya Fukuda, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Psychopharmacology
|
September 17, 2008
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
Masataka Wakeno, Masaki Kato, Gaku Okugawa, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis
Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.
Neuropsychobiology
|
November 27, 2015
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Journal of Affective Disorders
|
July 19, 2023
Relationship between circulating mitochondrial DNA and microRNA in patients with major depression
Haruhiko Ogata, Koichiro Higasa, Yuki Kageyama, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2015
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Diabetes Care
|
January 28, 2003
MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation
Makiko Maeda, Isamu Yamamoto, Masakatsu Fukuda, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 29, 2015
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
Yoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
December 3, 2015
Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study
Azusa Suwa, Keiichiro Nishida, Keita Utsunomiya, et al.
International Journal of Cardiology
|
December 19, 2012
Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study
Hiroshi Okamoto, Masatsugu Hori, Masunori Matsuzaki, et al.
European Journal of Clinical Pharmacology
|
March 11, 2019
Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients
Maki Sasano, Masako Ohno, Yuya Fukuda, et al.
Page
of 4